London, UK and Boston, MA, USA, 29 April 2008 - Abingworth, the international life sciences investment group, today announced the appointment of David Mayer as Partner. He will be based at the Company’s offices in Waltham, MA, USA and his prime responsibility will be to support Abingworth’s efforts in growth equity, which will include expansion and acquisition financings, small buyouts and build-ups in healthcare and life science companies. Abingworth plans to invest from £10 million ($20 million) to up to £40 million ($80 million) in each of its growth equity investments.

Read full article